Insider Transactions in Q3 2022 at Seres Therapeutics, Inc. (MCRB)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 05
2022
|
Nutritional Health Ltp Fund General Partner LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
8,738,243
+41.57%
|
$26,214,729
$3.15 P/Share
|
|
Jul 05
2022
|
Eric D. Shaff CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
63,492
+39.73%
|
$190,476
$3.15 P/Share
|
|
Jul 05
2022
|
Meryl Zausner Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,746
+50.0%
|
$95,238
$3.15 P/Share
|
|
Jul 05
2022
|
Matthew R. Henn |
BUY
Grant, award, or other acquisition
|
Direct |
47,619
+50.0%
|
$142,857
$3.15 P/Share
|
|
Jul 05
2022
|
David S. Ege |
BUY
Grant, award, or other acquisition
|
Direct |
31,746
+50.0%
|
$95,238
$3.15 P/Share
|
|
Jul 05
2022
|
Thomas Des Rosier Chief Legal Officer and EVP |
BUY
Grant, award, or other acquisition
|
Direct |
63,492
+37.78%
|
$190,476
$3.15 P/Share
|
|
Jul 05
2022
|
Willard H Dere |
BUY
Grant, award, or other acquisition
|
Direct |
31,746
+50.0%
|
$95,238
$3.15 P/Share
|
|
Jul 05
2022
|
Paula Cloghessy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,746
+50.0%
|
$95,238
$3.15 P/Share
|
|
Jul 05
2022
|
David Arkowitz Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,492
+49.22%
|
$190,476
$3.15 P/Share
|
|
Jul 05
2022
|
Richard N Kender |
BUY
Grant, award, or other acquisition
|
Direct |
63,492
+50.0%
|
$190,476
$3.15 P/Share
|
|
Jul 05
2022
|
Paul Biondi |
BUY
Grant, award, or other acquisition
|
Direct |
47,619
+50.0%
|
$142,857
$3.15 P/Share
|